Evommune, Inc. — Form D
Evommune, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-08. The offering totals $57.5M, of which $57.5M was reported sold. Industry: Other.
Offering
- Filed: 2025-01-08
- Form: D
- Accession: 0002044725-25-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $57.5M
- Amount sold: $57.5M
- Investors: 16
- Date of first sale: 2023-03-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-534516
Issuer
- Name: Evommune, Inc.
- CIK: 0002044725
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1841 PAGE MILL RD, PALO ALTO, CA, 94304
- Phone: (650) 223-7745
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| David Cohen | Director | Buffalo, NY |
| Derek DiRocco | Director | Boston, MA |
| Eugene Bauer | Director | Redwood City, CA |
| Eugene Bauer | Executive Officer | Redwood City, CA |
| Felice Verduyn-van Weegen | Director | Palo Alto, CA |
| Robert Hopfner | Director | Palo Alto, CA |
| Kyle Carver | Executive Officer | Palo Alto, CA |
| Gregory Moss | Executive Officer | Palo Alto, CA |
| Francois Beaubien | Director | Palo Alto, CA |
| Benjamin McGraw | Director | Palo Alto, CA |
| Jeegar Patel | Executive Officer | Palo Alto, CA |
| Yuexin Yu | Director | Palo Alto, CA |
| Janice Drew | Executive Officer | Palo Alto, CA |
| Luis Pena | Director | Palo Alto, CA |
| Luis Pena | Executive Officer | Palo Alto, CA |
Other filings by this issuer (3)
More